This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Conflicted on These Materials Names: Ivanhoe Mines (OtherIVPAF) and International Flavors & Fragrances (IFF)

Tipranks - Thu Aug 13, 7:52AM CDT

Analysts have been eager to weigh in on the Materials sector with new ratings on Ivanhoe Mines (IVPAF) and International Flavors & Fragrances (IFF).

Claim 55% Off TipRanks

Ivanhoe Mines (IVPAF)

Jefferies analyst Fahad Tariq maintained a Hold rating on Ivanhoe Mines yesterday and set a price target of C$13.00. The company’s shares closed last Tuesday at $8.53, close to its 52-week low of $8.38.

According to TipRanks.com, Tariq is a 5-star analyst with an average return of 17.3% and a 71.3% success rate. Tariq covers the Basic Materials sector, focusing on stocks such as Pan American Silver, G Mining Ventures, and Hudbay Minerals. ;'>

Ivanhoe Mines has an analyst consensus of Moderate Buy, with a price target consensus of $9.89, representing a 16.5% upside. In a report issued on July 30, RBC Capital also maintained a Hold rating on the stock with a C$15.00 price target.

See the top stocks recommended by analysts >>

International Flavors & Fragrances (IFF)

In a report released today, David Begleiter from Deutsche Bank reiterated a Buy rating on International Flavors & Fragrances, with a price target of $100.00. The company’s shares closed last Tuesday at $85.00.

According to TipRanks.com, Begleiter is a 3-star analyst with an average return of 1.8% and a 53.2% success rate. Begleiter covers the Basic Materials sector, focusing on stocks such as Compass Minerals International, Air Products and Chemicals, and H.B. Fuller Company. ;'>

Currently, the analyst consensus on International Flavors & Fragrances is a Strong Buy with an average price target of $97.17, a 14.5% upside from current levels. In a report issued on August 5, Barclays also maintained a Buy rating on the stock with a $90.00 price target.

Read More on IVPAF:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.